UK Cyber Security Council opens membership application process
Member organisations will be able to make committee nominations as the Council prepares to commence…
Month: August 2021
UKCloud launches specialist Strategic Data Practice in support of the National Data Strategy
UKCloud’s new Strategic Data Practice enables public sector organisations to successfully achieve digital transformation by…
LIDDS Interim report January – June 2021
JANUARY – JUNE 2021 Net sales amounted to MSEK 0.8 (0.0) Operating expenses amounted to…
Saniona publishes its interim report for the second quarter of 2021
PRESS RELEASE August 26, 2021 Three Months Ended June 30, 2021 (2020)Revenue was SEK 1.9…
Immunicum AB (publ) Interim Report April – June 2021
Press Release 26 August 2021 Immunicum AB (publ) Interim Report April – June 2021 FINANCIAL…
Sequana Medical Notice of 2021 Half Year Results and Business Update
GHENT, Belgium, Aug. 26, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the…
HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced Triple Negative Breast Cancer or Advanced Endometrial Cancer
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 25, 2021 (GLOBE NEWSWIRE) —…
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer Therapies
Common stock and warrants expected to commence trading on Nasdaq on August 26, 2021 under…
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
YARDLEY, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) — OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused…
Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results
– Announced U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment…
Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA…
Opiant Pharmaceuticals to Participate in September Investor Conferences
SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today…
Bioventus Invests in Trice Medical Minimally Invasive Technologies
Bioventus Also Agrees to OUS Distribution and Co-Development Relationships DURHAM, N.C., Aug. 25, 2021 (GLOBE…
Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company
Orders Support Company’s Recently Increased 2021 Guidance REDWOOD CITY, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE)…
BioCryst Announces Acceptance of Regulatory Applications for ORLADEYO® (berotralstat) by Health Canada and Swissmedic
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
INmune Bio, Inc. Announces Biomarker Data Demonstrating that the First Patient Treated with its NK Cell Priming “Pseudokine”, INKmune™, Successfully Produced Memory-Like NK Cells
First positive clinical confirmation of in vivo NK response, mirroring in vitro data Boca Raton,…
Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
– SKYTROFA, the first FDA approved treatment utilizing TransCon™ technology, is a long-acting prodrug of…
AB Science announces that it has received a second authorization to resume patient enrollment, in the Phase 3 study of masitinib in mastocytosis
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED A SECOND AUTHORIZATION TO RESUME PATIENT…
Sanofi: Information concerning the total number of voting rights and shares – July 2021
Information concerning the total number of voting rights and shares, provided pursuant to article L….
data.world enhances data accessibility with universal BI and analytics tool support
AUSTIN, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) — data.world, the cloud-native enterprise data catalog company,…